ORCID
Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE). Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Biomedicina from Faculdades Integradas Brasil Amazônia (2017) and master's at Ciências da Saúde from Instituto Israelita de Ensino e Pesquisa Albert Einstein (2022). Has experience in Medicine (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Immunotherapies using chimeric antigen receptor (CAR) anti-CD19 T cells have demonstrated surprising clinical efficacy against B-cell malignancies. However, the treatment of relapsed and refractory (R/R) acute myeloid leukemia (AML) has low cure rates. Despite the encouraging results with CAR-T therapy, the number of patients who relapse after treatment is worrying, with antigen loss bein…
| 1 / 1 | Ongoing scholarships in Brazil |
| Associated processes | |